AtriCure Europe

AtriCure, Inc. provides innovative technologies for the treatment of atrial fibrillation (AF) and related conditions. AF affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of AF and reduction of AF-related complications. Our focus is on treating the most serious types of AF — persistent and long-standing persistent  — and managing post-operative pain. We offer physicians solutions across our four franchises: open ablation, minimally invasive ablation, appendage management and pain management.